Despite relatively few strong research studies supporting methodologies for improving adherence to medications for patients with heart failure, Medtronic's recent press release suggests their cardiac resynchronization therapy (CRT) implants might do the trick.
Medtronic accounced results of a retrospective analysis of administrative claims data of more than 4,500 patients with heart failure at the 2016 Heart Failure Society of America Scientific Meeting, Monday.
The analysis found that the number of patients "fully compliant" to a regimen of guideline-recommended medications "nearly doubled" at twelve months following CRT implants compared to those who did not receive implants.
Continue reading Improving adherence to medications for heart failure: Medtronic says their CRT does it
Statins are a big question in cardiac care.
Kaiser Permanente proudly reported last week the increased adoption of their daily statin regimen, but is the increased use of statins positive or negative?
The medication regimen bundles two generic drugs - a cholesterol-lowering statin and a blood pressure-lowering drug in daily doses to patients with diabetes or heart disease.
In 2009, Kaiser Permanente released a study showing that their protocol lowers the chance of hospitalization for heart attack or stroke the following year by more than 60 percent.
Continue reading Can Statins Reduce Heart Risk? – Cardiac News Round-Up